ESGEX | FFPNX | ESGEX / FFPNX | |
Total Expense Ratio | 0.95 | 0.51 | 186% |
Annual Report Gross Expense Ratio | 1.12 | 0.51 | 220% |
Fund Existence | 6 years | 5 years | - |
Gain YTD | 14.928 | 14.793 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 96M | 158B | 0% |
Annual Yield % from dividends | 0.51 | 0.70 | 74% |
Returns for 1 year | 16.65 | 17.31 | 96% |
Returns for 3 years | 48.37 | 47.27 | 102% |
Returns for 5 years | 68.71 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CSMDX | 15.73 | 0.09 | +0.58% |
Copeland SMID Cap Dividend Growth I | |||
SHSCX | 45.89 | 0.22 | +0.48% |
BlackRock Health Sciences Opps Inv C | |||
FCUEX | 20.01 | 0.08 | +0.40% |
NYLI PineStone U.S. Equity Class A | |||
CLCRX | 23.99 | 0.07 | +0.29% |
Columbia Select Large Cap Equity Inst2 | |||
LVAFX | 11.43 | -0.02 | -0.17% |
LSV Global Managed Volatility Investor |